Wednesday , October 5 2022

In 10 years, 15% of diabetics have been added, with growth over time becoming unrealistic


Update: 07.11.2018 18:21

Prague – In the past 10 years, 15 percent of diabetics were treated, last year almost 930,000. Other people do not yet know about their diagnosis. The treatment of these patients is about 13 percent of the total health care costs, on average it is 53,000 crowns per patient. Information today was given at the press conference of the Czech Association of Pharmaceutical Companies (ČAFF) on World Diabetes Day, which is celebrated on November 14th.

About 90 percent of diabetics have diabetes of the second type, which is half genetically conditioned and the other half forms an unhealthy lifestyle. According to DiaVize's head of diabetes, Marty Klement's diabetes, 30 minutes of physical activity, including walking or gardening, reduces the risk of diabetes by as much as a third.

For type 2 diabetes, the body has a surplus of insulin that can not be released as quickly as the patient needs. In addition, their own insulin does not work as it is, and so-called insulin resistance occurs.

Last year, about 33 billion crowns were spent on the treatment of second-class diabetes in the Czech Republic, with a total of about 300 billion in healthcare. If the number of diabetics had risen at the same rate as before, in 2035 every ten Czechs will suffer. "Permanent growth will become unrealistic over time," Klement added.

Patients typically take a combination of up to four drugs for diabetes, another for blood pressure or high cholesterol. "Patients are not treated with a combination of ten drugs because if they do not follow the diet, their glycemia will not be as standard," said Klement, saying that the cost of working with the patient and his lifestyle is much lower and often more effective than healing. More than a third of them do not follow the doctors' treatment.

The Czech Diabetology Society supports the education of patients. Studies show that group therapies are even more effective than individual talking to the patient. From next year, according to Clement, health insurance companies will also pay. "The problem is to get the patients there, but if they come back, they come back more often than regular checks," she added.

The patient who changes his lifestyle can achieve such an improvement that he will not have to take so many medicines and will be cheaper for the health system. Martin Mátl, director of the ČAFF, is also trying to save the costs of public health insurance by introducing so-called generic medicines, a copy of the original medicines that ended patent protection. An example is the medicine of merformin, which is used by most diabetics. Over the last ten years, according to Math, the generic has saved 3.7 billion crowns.

In addition, diabetics do not only treat symptoms that are directly associated with diabetes but more often suffer from chronic complications such as heart disease and kidney failure. The risk of a stroke increases diabetes by two to four times, five times infarction, heart failure or coronary artery disease.





Source link